Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proinflammatory cytokines in allergic rhinitis

C Bachert1, U Hauser, B Prem

  • 1ENT Department, University of Düsseldorf, Germany.

European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
|January 1, 1995
PubMed
Summary

Proinflammatory cytokines like interleukin-1 and tumor necrosis factor-alpha drive allergic rhinitis by increasing adhesion molecules in nasal tissue. Inhibiting these cytokines offers a promising therapeutic target for allergic inflammation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].

Laryngo- rhino- otologie·2026
Same author

Real-world effectiveness of omalizumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP): findings from CHRINOSOR.

Rhinology·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI].

HNO·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 2: Hypersensitivity reactions of type V (epithelial barrier defects)].

HNO·2025
Same author

Indication for biologics in a real-world cohort of dupilumab treated chronic rhinosinusitis with nasal polyps patients according to international recommendations: evidence from the European CRS Outcome Registry (CHRINOSOR).

Rhinology·2025
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 1: Hypersensitivity reactions of type IVa-c as a correlate to T1, T2, and T3 endotypes].

HNO·2025

Area of Science:

  • Immunology
  • Allergy Research
  • Inflammation Biology

Background:

  • Allergic rhinitis involves complex immune responses with significant cell-to-cell communication.
  • Cytokines and adhesion receptors are crucial in the late phase of allergic reactions.
  • Understanding these molecular interactions is key to developing new treatments.

Purpose of the Study:

  • To investigate the role of proinflammatory cytokines in allergic rhinitis.
  • To examine the expression and regulation of adhesion receptors in nasal mucosa.
  • To evaluate potential therapeutic targets for allergic inflammation.

Main Methods:

  • Detection of cytokines (IL-1, IL-8, TNF-alpha) in nasal secretions and mucosa using ELISA and immunohistochemistry.
  • Analysis of adhesion receptor expression in nasal mucosa from allergic rhinitis patients.

Related Experiment Videos

  • Establishment of an in vitro model using nasal mucosa to study cytokine-induced receptor upregulation.
  • Inhibition studies using soluble cytokine receptors, antagonists, and prednisolone.

    • Main Results:

    • Proinflammatory cytokines (IL-1, IL-8, TNF-alpha) were detected in nasal tissues of allergic rhinitis patients.
    • Increased expression of adhesion receptors was observed in allergic nasal mucosa, suggesting a role in cell migration.
    • In vitro, E-selectin was significantly upregulated by IL-1 beta, TNF-alpha, and allergen exposure.
    • Allergen-induced E-selectin upregulation was inhibited by soluble cytokine receptors, IL-1ra, and prednisolone.

    Conclusions:

    • Proinflammatory cytokines are key mediators in upregulating adhesion processes in human nasal mucosa.
    • These cytokines contribute to the activation of cell populations involved in allergic inflammation.
    • Targeting these cytokine-driven adhesion mechanisms presents a promising therapeutic strategy for allergic diseases.